US HB2855 | 2021-2022 | 117th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on April 26 2021 - 25% progression, died in committee
Action: 2021-04-27 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 26 2021 - 25% progression, died in committee
Action: 2021-04-27 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to add a new set of measures to the 5-star rating system under the Medicare Advantage program in order to encourage increased access to biosimilar biological products.
Title
Star Rating for Biosimilars Act
Sponsors
Rep. Paul Tonko [D-NY] | Rep. Bob Gibbs [R-OH] |
History
Date | Chamber | Action |
---|---|---|
2021-04-27 | House | Referred to the Subcommittee on Health. |
2021-04-26 | House | Referred to the Subcommittee on Social Security. |
2021-04-26 | House | Referred to the Subcommittee on Health. |
2021-04-26 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2021-04-26 | House | Introduced in House |
Same As/Similar To
HB5260 (Related) 2022-11-01 - Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
HB5237 (Related) 2022-11-01 - Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
HB5237 (Related) 2022-11-01 - Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/117th-congress/house-bill/2855/all-info |
Text | https://www.congress.gov/117/bills/hr2855/BILLS-117hr2855ih.pdf |